|
|
Article: Reality Perspectives at the 5th European C21 BioVentures Conference.
- Article from:
- Business Wire
- Article date:
- March 31, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON -- The 5th Annual European C21 BioInvestor (EC21) conference was held last week at the QEII Conference Centre, London. Over 250 people registered for the two-day event, from both the specialist investment community and the global biotech industry.
The first session of the conference was a new edition to EC21. The "Best in Show - Business Plan Competition," saw Dr. Jonathan Kil, President & CEO of Sound Pharmaceuticals Incorporated (SPI), receiving the trophy for the best investment merits of his business plan. SPI is an early stage biopharmaceutical company in Seattle, WA, whose goal is to develop drugs that will prevent and treat hearing loss.
...